Papers - YAMAMOTO Hayato
-
The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.
Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C
World journal of urology 39 ( 1 ) 169 - 175 2021.1
-
Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.
Konishi S, Hatakeyama S, Imai A, Kumagai M, Okita K, Togashi K, Hamaya T, Hamano I, Okamoto T, Iwamura H, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Lower urinary tract symptoms 13 ( 1 ) 56 - 63 2021.1
-
Intraoperative upper urinary tract cytology examination is a risk factor of upper urinary tract recurrence in patients with non-muscle-invasive bladder cancer.
Fujita N, Hatakeyama S, Okita K, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
Urologic oncology 39 ( 1 ) 75.e9 - 75.e16 2021.1
-
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.
Konishi S, Hatakeyama S, Imai A, Kumagai M, Okamoto T, Okita K, Hamano I, Narita T, Kojima Y, Iwamura H, Yamamoto H, Yoneyama T, Yoneyama T, Hashimoto Y, Ohyama C
Urologia internationalis 105 ( 3-4 ) 232 - 239 2021
-
尿路結石形成に関与する糖鎖変異オステオポンチンの検索
阿南 剛, 橋本 安弘, 佐藤 信, 大山 力, 米山 徹, 野呂 大輔, 飛澤 悠葵, 畠山 真吾, 米山 美穂子, 山本 勇人, 今井 篤, 米山 高弘
日本内分泌学会雑誌 97 ( 0 ) 47 - 49 2021
-
RARCと回腸を利用した尿路変向術
米山 高弘, 畠山 真吾, 橋本 安弘, 大山 力, 富樫 赳, 堀口 裕貴, 小玉 寛健, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人
Japanese Journal of Endourology 34 ( 1 ) 24 - 32 2021
-
Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study
Tanaka Toshikazu, Ohyama Chikara
international journal of urology 2020.12
-
Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study.
Tanaka T, Hatakeyama S, Numakura K, Kido K, Noro D, Oikawa M, Hosogoe S, Tokui N, Yamamoto H, Narita S, Ito H, Yoneyama T, Hashimoto Y, Kawaguchi T, Habuchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 27 ( 12 ) 1095 - 1100 2020.12
-
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)
hamaya tomoko, Ohyama Chikara
International Journal of Clinical Oncology 2020.10
-
Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Yasushi Mariya, Chikara Ohyama
Clinical genitourinary cancer 18 ( 5 ) e523 - e530 2020.10
-
Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
Urologic oncology 38 ( 10 ) 795.e9 - 795.e17 2020.10
-
Safety and Feasibility of Radiation Therapy to the Primary Tumor in Patients With Metastatic Castration-resistant Prostate Cancer.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Mariya Y, Ohyama C
Clinical genitourinary cancer 18 ( 5 ) e523 - e530 2020.10
-
Geriatric 8 screening of frailty in patients with prostate cancer
masaki momota, chikara ohyama
international journal of urology 2020.8
-
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Koichi Kido, Takuma Narita, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 38 ( 8 ) 684.e17 - 684.e24 2020.8
-
The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan
teppei okamoto, ohyama chikara
International urological nephrology 2020.8
-
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
Okita K, Hatakeyama S, Momota M, Soma O, Hamano I, Tanaka T, Iwamura H, Fujita N, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Yoshikawa K, Kawaguchi T, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 649 - 654 2020.8
-
The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.
Okamoto T, Hatakeyama S, Imai A, Yamamoto H, Yoneyama T, Mori K, Yoneyama T, Hashimoto Y, Nakaji S, Ohyama C
International urology and nephrology 52 ( 8 ) 1421 - 1428 2020.8
-
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Fujita N, Hatakeyama S, Momota M, Kido K, Narita T, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
Urologic oncology 38 ( 8 ) 684.e17 - 684.e24 2020.8
-
Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama T, Yamamoto H, Imai A, Ito H, Yoneyama T, Hashimoto Y, Yoshikawa K, Ohyama C
Urologic oncology 38 ( 8 ) 684.e1 - 684.e8 2020.8
-
Geriatric 8 screening of frailty in patients with prostate cancer.
Momota M, Hatakeyama S, Soma O, Tanaka T, Hamano I, Fujita N, Okamoto T, Yoneyama T, Yamamoto H, Imai A, Yoshikawa K, Yoneyama T, Hashimoto Y, Ohyama C
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2020.8